Novel 3D organotypic urothelial cell culture model for identification of new therapeutic approaches in urological infections.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
03 2020
Historique:
received: 23 09 2019
revised: 27 12 2019
accepted: 20 01 2020
pubmed: 28 1 2020
medline: 25 5 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

3D organotypic cell cultures offer the possibility to study cell growth in a more in vivo like situation. To our knowledge no 3D culture of primary urothelial cells has been established yet. BK Polyomavirus (BKPyV), replicating in urothelial cells, may cause haemorrhagic cystitis in immunocompromised patients. Establishment of a 3D organotypic cell culture of primary urothelial cells and fibroblasts; use of this model as infection model for archetype BKPyV; description of first parts of viral life cycle with identification of therapeutic targets. This is an experimental study. Primary urothelial cells were purchased from CellnTec, Bern, Switzerland; fibroblasts were isolated from the ureter of patients with no urothelial malignancy in their medical history. As main methods we used quantitative real-time PCR and immunohistochemistry. Outcomes were analysed using SPSS 23.0. We were able to develop a 3D organotypic culture for primary urothelium. An infection with archetype BKPyV was established in this model with virus replication rates up to 6.41 × 108 copies/ml on day 9 following Infection. Interestingly, proliferation rate of the urothelial cells is significantly (p = 0.049 at day 6 following infection) elevated while cells are losing differentiation under infection. Phosphorylated STAT3 is also significantly elevated (p < 0.0001) during infection. The established of urothelial 3D cultures is a new method to study several urothelial diseases. The archetype BKPyV infection model is novel and the first method to study archetype viral life cycle. The STAT3 pathway might be an interesting target for the development of a causal therapy.

Identifiants

pubmed: 31986366
pii: S1386-6532(20)30025-1
doi: 10.1016/j.jcv.2020.104283
pii:
doi:

Substances chimiques

Antiviral Agents 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104283

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Laila Schneidewind (L)

University Medicine Rostock, Department of Urology, Rostock, Germany. Electronic address: laila.schneidewind@med.uni-rostock.de.

Thomas Neumann (T)

University Medicine Greifswald, Department of Haematology and Oncology, Greifswald, Germany.

Andrzej Plis (A)

University Medicine Greifswald, Department of Haematology and Oncology, Greifswald, Germany.

Sascha Brückmann (S)

University Medicine Greifswald, Dept. of Pathology, Greifswald, Germany.

Markus Keiser (M)

University Medicine Greifswald, Department of Clinical Pharmacology, Greifswald, Germany.

William Krüger (W)

University Medicine Greifswald, Department of Haematology and Oncology, Greifswald, Germany.

Christian Andreas Schmidt (CA)

University Medicine Greifswald, Department of Haematology and Oncology, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH